Back to 
MOORE CAPITAL MANAGEMENT, LP
MOORE CAPITAL MANAGEMENT, LPBRBRIDGEBIO PHARMA INC
1 quarters
Position history for MOORE CAPITAL MANAGEMENT, LP's holdings in BRIDGEBIO PHARMA INC
Yes. Moore Capital Management holds 31,930,000 shares of BRIDGEBIO PHARMA, worth $56.9M, as of its Q2 2026 13F filing. It opened the position in Q2 2026. BRIDGEBIO PHARMA is 0.8% of Moore Capital Management's reported 13F portfolio.
Current Value
$56.9M
Current Shares
31.9M
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History